The Dementia Trials Accelerator (DTA) – which will be spearheaded by the UK Dementia Research Institute (UK DRI) and Health ...

The World Anti-Doping Agency (WADA) has announced the 2025 List of Prohibited Substances and Methods, including the Summary ...

National Patient Safety Alert (NatPSA) : Issued on 27 September 2023, highlighting shortages of methylphenidate prolonged-release capsules and tablets, lisdexamfetamine capsules, and guanfacine ...

The International Tennis Integrity Agency (ITIA) has reacted this week to the Prohibited List published in September by the ...

The most prescribed medications are methylphenidates, mixed amphetamine salts, atomoxetine and guanfacine. Each of these medications has distinct pharmacokinetic profiles. When it comes to ...

In a world where attention deficit hyperactivity disorder (ADHD) is increasingly recognized, the quest for effective management options grows ever more urgent. Many people are turning to Adderall ...